Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lianggui Xiao"'
Autor:
Lianggui Xiao, Mingming Li, Yang Xiao, Lin Yu, Yu Li, Zhiwang Zhang, Guo Zhang, Yixing Li, Lei Zhou, Yunxiao Liang
Publikováno v:
Phytotherapy Research.
Autor:
Mingming Li, Yang Xiao, Lianggui Xiao, Yu Li, Mengting Jia, Yu Sun, Tingli Pan, Lei Zhou, Yixing Li
Publikováno v:
Food & Function. 13:7260-7273
As living standards improve, obesity has become an increasingly serious health problem. Natural extracts from a wide range of sources are non-toxic and have significant potential as drugs for the prevention and treatment of obesity. We assessed 243 n
Autor:
Yang Xiao, Lianggui Xiao, Mingming Li, Songsong Liu, Yuwei Wang, Liang Huang, Siqi Liu, Tianyu Jiang, Lei Zhou, Yixing Li
Publikováno v:
Foodfunction.
Metabolic associated fatty liver disease is the main cause of chronic liver disease in the world, but there is still no effective treatment. In the search for drugs to treat liver steatosis, we screened 303 natural products using HepG2 cells and disc
Autor:
Liang Huang, Qichao Liao, Tingli Pan, Yu Sun, Zhier Aluo, Lianggui Xiao, Jingsu Yu, Siqi Liu, Yang Xiao, Yufeng Yang, Yixing Li, Lei Zhou
Publikováno v:
International journal of biological sciences. 18(15)
The small intestine is main site of exogenous lipid digestion and absorption, and it is important for lipid metabolic homeostasis. Cell death-inducing DNA fragmentation-factor like effector C (CIDEC) is active in lipid metabolism in tissues other tha
Autor:
Yang Xiao, Zeqiang Ma, Yixing Li, Haojie Zhang, Siqi Liu, Zupeng Luo, Liang Huang, Zhiwang Zhang, Zhier Aluo, Lei Zhou, Lin Yu, Ziyi Song, Mengting Jia, Lianggui Xiao
Publikováno v:
British journal of pharmacologyREFERENCES. 179(11)
BACKGROUND AND PURPOSE Nonalcoholic fatty liver disease (NAFLD) affects over 25% of the general population and lacks an effective treatment. Recent evidence implicates disrupted mitochondrial calcium homeostasis in the pathogenesis of hepatic steatos